The severity of valvular heart disease in euthyroid individuals is associated with thyroid hormone levels but not with TSH levels

Front Endocrinol (Lausanne). 2023 Jul 4:14:1193557. doi: 10.3389/fendo.2023.1193557. eCollection 2023.

Abstract

Background: Abnormal thyroid function is a metabolic disorder and can lead to several complications, including cardiovascular diseases. In this study, we aimed to examine the relationship between clinical traits and outcomes and the thyroid hormone level of euthyroid individuals with valvular heart disease (VHD).

Method: The thyroid function was evaluated in 526 euthyroid VHD patients and 155 healthy control people. As well as clinical indicators were collected and analyzed.

Results: No difference in TSH levels (p>0.05) was recorded; however, fT3, TT3, and TT4 levels were lower in the euthyroid VHD patients than in healthy control(4.3 vs 4.63; 1.37 vs 1.48; 97.7 vs 102.09, respectively, all p<0.05), while the fT4 level was higher (12.91 vs 12.35, p<0.05). Moreover, all showed a continuous trend with the change of NYHA grade which does not consist of the incidence of euthyroid sick syndrome(ESS). Further analysis showed that for every 10-fold increase in BNP, fT4 increases by 83%, fT3 decreases by 30%, and TT3 decreases by 12% after being adjusted for other influencing factors. Meanwhile, adjusted fT4 was correlated with multiple worse clinical indicators, which were influenced by age.

Conclusion: Thyroid hormones are widely regulated in VHD patients even with acceptable cardiac function, except for TSH level. And the adjusted fT4 is related to worse clinical indicators and outcomes which are only recorded in patients under 53 years old.

Keywords: NYHA grades; age; euthyroid sick syndrome; thyroid hormone; valvular heart disease.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Euthyroid Sick Syndromes* / epidemiology
  • Euthyroid Sick Syndromes* / etiology
  • Heart Valve Diseases*
  • Humans
  • Middle Aged
  • Thyroid Hormones
  • Thyrotropin

Substances

  • Thyroid Hormones
  • Thyrotropin

Grants and funding

This study was sponsored by grants from the National Natural Science Foundation of China (81802504, a grant from the Sichuan Medical Association (Q19037), grants of Sichuan Science and Technology Bureau (2021YFS0380, 2022YFH0005, 2023YFH0010), and a grant from the Chengdu Science and Technology Bureau (2021-YF05-00225-SN), and a grant from the China Foundation for International Medical Exchange (No. z-2016-23-2101-05) and a grant from The Research Project on Cadre Health in Sichuan Province (2021-212).